Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies (Q36694734)
Jump to navigation
Jump to search
scientific article published on March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies |
scientific article published on March 2004 |
Statements
1 reference
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies (English)
1 reference
J J Body
1 reference
I J Diel
1 reference
M Lichinitzer
1 reference
A Lazarev
1 reference
M Pecherstorfer
1 reference
R Bell
1 reference
D Tripathy
1 reference
B Bergstrom
1 reference
1 March 2004
1 reference
1 reference
1133-1137
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference